Citation Impact
Citing Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Pediatric Graves’ disease: management in the post-propylthiouracil Era
2014
Carbimazole embryopathy: An emerging phenotype
2004
HYPERTHYROIDISM IN PREGNANCY
1998
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
Is a more active attitude warranted in patients with subclinical thyrotoxicosis?
1990
Tear dynamics and dry eye
1998 Standout
Pediatric Graves’ Disease: Controversies in Management
2010
Isolation and characterization of human cDNA clones encoding the .alpha. and the .alpha.' subunits of casein kinase II
1990 StandoutNobel
Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study
2015
Management of neonates born to women with Graves' disease: a cohort study
2014
Serum levels of IgG and IgG4 in Hashimoto thyroiditis
2013
The Use of Antithyroid Drugs in Pregnancy and Lactation
2001
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
2011
Schwannomatosis
1996
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Thyroid Function and Hyperfunction During Gestation
1993
Efficacy of a cell phone-based exercise programme for COPD
2008
Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations
1993
Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism
2014
Thyroid Hormone and the Cardiovascular System
2001 Standout
Hyperthyroidism in pregnancy
2004
Antithyroid Drugs
2005
The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary‐care community hospital
2008
Predictors of Autoimmune Hyperthyroidism Relapse in Children after Discontinuation of Antithyroid Drug Treatment
2008
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Subclinical Hyperthyroidism
2001
Positive Impact of Long-Term Antithyroid Drug Treatment on the Outcome of Children with Graves' Disease: National Long-Term Cohort Study
2011
Graves' Ophthalmopathy
2010 Standout
THYROTOXICOSIS AND THE HEART
1998
Clinical applications of two-dimensional electrophoresis
1995
Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Graves’ Hyperthyroidism
1997
Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy
2008
Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism
2008
Thyroid Disease and Pregnancy
1991
Treatment of Graves' Disease with Antithyroid Drugs in the First Trimester of Pregnancy and the Prevalence of Congenital Malformation
2012
Choanal atresia and athelia: Methimazole teratogenicity or a new syndrome?
1987
Therapy Insight: management of Graves' disease during pregnancy
2007
The Effectiveness of Nurse-Led, Home-Based Pulmonary Rehabilitation in Patients with COPD in Turkey
2011
Endocrine and liver interaction: the role of endocrine pathways in NASH
2009
Review of Antithyroid Drug Use During Pregnancy and Report of a Case of Aplasia Cutis
1994
Choanal atresia and hypothelia following methimazole exposure in utero: A second report
1998
Subclinical Thyroid Disease
2004 Standout
Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients
2016
Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment
2008
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
2011
Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case–control study
2008
The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil
2006
IgG4-related disease
2014 Standout
The Use and Misuse of Thyroid Hormone*
1993
Autoimmune thyroid disease and pregnancy
1996
Birth Defects After Early Pregnancy Use of Antithyroid Drugs: A Danish Nationwide Study
2013
Fetal and neonatal thyroid function in relation to maternal Graves' disease
2004
Adverse effects of prenatal methimazole exposure
2001
Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy
1994
Fetal and Neonatal Hyperthyroidism
1999
The Human Plasma Proteome
2002 Standout
Treatment of thyroid disorders before conception and in early pregnancy: a systematic review
2012
Expression and Activity of G Protein-Coupled Receptor Kinases in Differentiated Thyroid Carcinoma
2002
THERAPY OF ENDOCRINE DISEASE: Antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
2014
Thyrotoxicosis, atrial fibrillation, and embolism, revisited
1989
Graves' Disease
2008
Frequency and characteristics of TBII‐seronegative patients in a population with untreated Graves’ hyperthyroidism: a prospective study
2008
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Overt and Subclinical Hypothyroidism Complicating Pregnancy
2002 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Analysis of 90 Cases of Antithyroid Drug-Induced Severe Hepatotoxicity Over 13 Years in China
2014
Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism
2014
Antithyroid Drug Treatment for Graves' Disease in Children: A Long-Term Retrospective Study at a Single Institution
2013
Methimazole-Induced Agranulocytosis in Patients with Graves' Disease Is More Frequent with an Initial Dose of 30 mg Daily than with 15 mg Daily
2009
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Antineutrophil Cytoplasmic Antibody–Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Engineering Adolescence
2014 Standout
Clinical Utility of TSH Receptor Antibodies
2013
Hepatotoxicity and cutaneous reactions after antithyroid drug administration
2012
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Accumulation and Endocrine Disrupting Effects of the Flame Retardant Mixture Firemaster® 550 in Rats: An Exploratory Assessment
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Methimazole embryopathy: Delineation of the phenotype
1999
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Biochemical and physiologic effects of thyroid hormone on cardiac performance
1983
Analysis of 754 Cases of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan
2013
Influence of the thyroid state on the calcium transient in ventricular muscle
1986 StandoutNobel
Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle.
1988 StandoutNobel
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
1997 Standout
Antithrombotic Therapy in Atrial Fibrillation
1989
Shuttle Walking Test as Predictor of Survival in Chronic Obstructive Pulmonary Disease Patients Enrolled in a Rehabilitation Program
2010
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
1995 Standout
Antithyroid Drug Therapy for Graves' Disease during Pregnancy
1986
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
THE INFLUENCE OF ENDOCRINE HORMONES ON THE AUTONOMIC NERVOUS SYSTEM
1981
Identification of α-Fodrin as a Candidate Autoantigen in Primary Sjögren's Syndrome
1997 Science
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves’ Ophthalmopathy and Help to Predict Severity and Outcome of the Disease
2006
Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study
2014
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2007
Autoimmune Thyroid Disease and Pregnancy: Relevance for the Child
2003
Thyroid Hormone Regulation of Metabolism
2014 Standout
Thyroid Disorders of Pregnancy
1995
Methimazole, Carbimazole, and Congenital Skin Defects
1987
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
1993 Standout
Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs.
1987
Immunology of Autoimmune Thyroid Diseases
1982 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The safety and efficacy of antithyroid drugs
2005
Pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
2008
Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes.
1992
TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
1991 Standout
Heterogeneity of protein kinase NII
1986
Guidelines for the management of thyroid cancer
2014 Standout
Comparison of Atrial Fibrillation Recurrence Rates After Successful Electrical Cardioversion in Patients With Hyperthyroidism-Induced Versus Non-Hyperthyroidism-Induced Persistent Atrial Fibrillation
2008
Induction of Skin Fibrosis in Mice Expressing a Mutated Fibrillin-1 Gene
2000 StandoutNobel
Antithrombotic Therapy in Atrial Fibrillation
1992
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Short-Term Effects of β-adrenergic Antagonists and Methimazole in New-Onset Thyrotoxicosis Caused by Graves' Disease
2012
Growth Hormone Response to Thyrotropin-Releasing Hormone in the Urethane-Anesthetized Rat: Effect of Thyroid Status*
1985
Clinical Characteristics of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Caused by Antithyroid Drugs
2009
Thyroid-Stimulating Immunoglobulin Bioassay Using Cultured Human Thyroid Cells*
1981
Works of Noboru Hamada being referenced
Comprehensive pulmonary rehabilitation according to severity of COPD
2006
Frequency of appearance of myeloperoxidase‐antineutrophil cytoplasmic antibody (MPO‐ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO‐ANCA and clinical manifestations
2001
Lack of desensitization of 3',5'-cyclic AMP response to thyrotropin stimulation in differentiated thyroid carcinoma
1987
Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ Disease
2007
Thyroid-Stimulating Antibody is Related to Graves' Ophthalmopathy, But Thyrotropin-Binding Inhibitor Immunoglobulin is Related to Hyperthyroidism in Patients with Graves' Disease
2000
Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients
2006
Thyroid Microsomal Antigen in Graves' Thyroid is Not Different from That in Normal Thyroid.
1991
Increase of serum GH concentration following TRH injection in patients with primary hypothyroidism.
1976
TSH Receptor Antibody Measurements and Prediction of Remission in Graves' Disease Patients Treated with Minimum Maintenance Doses of Antithyroid Drugs
2006
Management of atrial fibrillation in the post-thyrotoxic state
1982
ANTI-THYROID PEROXIDASE ANTIBODY IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE: POSSIBLE IDENTITY WITH ANTI-MICROSOMAL ANTIBODY
1985
Adenosine 3′,5′-Monophosphate Concentrations and Responsiveness to Thyrotropin and Thyroid-Stimulating Immunoglobulins in Normal and Graves' Thyroids*
1980
Serum Dopamine-β-hydroxylase Activity in Thyroid Disorders
1974
Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism
2010
MATERNAL HYPERTHYROIDISM AND CONGENITAL MALFORMATION IN THE OFFSPRING
1984
Myasthenia gravis associaied with Graves' disease in Japan.
1987
Is it necessary to adjust the replacement dose of thyroid hormone to the season in patients with hypothyroidism?
1984
Occurrence of protein kinases NI and NII in human and porcine thyroids
1984
Effect of corticosteroids in 10 cases of methimazole-induced agranulocytosis.
1981
Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission
2010